During the past decade, Carle Foundation - Carle Cancer Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 6 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Carle Foundation - Carle Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 4 trials, followed by "BriaCell Therapeutics Corporation" with 1 trials sponsored, "Canadian Cancer Trials Group" with 1 trials sponsored, "ETOP IBCSG Partners Foundation" with 1 trials sponsored and "Exact Sciences Corporation" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Carle Foundation - Carle Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 3 trials as a collaborator, "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator and "ETOP IBCSG Partners Foundation" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Carle Foundation - Carle Cancer Center" are "Breast Cancer" (4 trials), "Adenocarcinoma of the Colon" (1 trials), "Adenocarcinoma of the Prostate" (1 trials), "Breast Cancer Metastatic" (1 trials) and "Breast Neoplasm" (1 trials). Many other conditions were trialed in "Carle Foundation - Carle Cancer Center" in a lesser frequency.

Most popular intervention types in "Carle Foundation - Carle Cancer Center" are "Drug" (10 trials), "Biological" (4 trials), "Other" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "3-dimensional conformal radiation therapy" (1 trials), "Avelumab" (1 trials), "Axitinib" (1 trials), "Cabozantinib" (1 trials) and "Cyclophosphamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Carle Foundation - Carle Cancer Center" are 7 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Carle Foundation - Carle Cancer Center". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Carle Foundation - Carle Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Carle Foundation - Carle Cancer Center, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".